HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Familial megalencephaly — Clinical Guidelines

Overview

Familial megalencephaly, often associated with genetic syndromes like Sotos syndrome or Weaver syndrome, refers to an enlarged brain size at birth and during early childhood, frequently accompanied by overgrowth and distinctive facial features. The condition can be linked to various genetic mutations affecting growth factors and signaling pathways 6.

Diagnosis

Genetic Testing: Identification of specific genetic mutations (e.g., NSD1 in Sotos syndrome, NSD2 in Weaver syndrome) 6.

Neuroimaging: MRI or CT scans showing enlarged brain volume and specific structural anomalies 6.

Clinical Features: Assessment of overgrowth, distinctive facial characteristics, and developmental milestones 6.

Management

Supportive Care: Focus on developmental support, physical therapy, and addressing associated comorbidities 6.

Genetic Counseling: Essential for families to understand inheritance patterns and risks 6.

Monitoring: Regular neurological and developmental assessments to manage complications 6.

Special Populations

Pediatrics: Early intervention programs crucial for developmental support 6.

Comorbidities: Management tailored to specific associated conditions like learning disabilities or behavioral issues 6.

Key Recommendations

Genetic Testing for Diagnosis: Utilize genetic testing to identify specific mutations associated with familial megalencephaly (Evidence: Expert opinion 6).

Comprehensive Developmental Monitoring: Regular evaluations by multidisciplinary teams including neurologists, developmental pediatricians, and therapists (Evidence: Expert opinion 6).

Family Genetic Counseling: Provide genetic counseling to families to understand inheritance and recurrence risks (Evidence: Expert opinion 6).

Tailored Supportive Therapies: Implement individualized supportive therapies addressing physical, cognitive, and behavioral needs (Evidence: Expert opinion 6).

1 2 3 4 5 6

References

1 Iatan I, Akioyamen LE, Ruel I, Guerin A, Hales L, Coutinho T et al.. Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis. European heart journal 2024. link 2 Bordat C, Cuerq C, Halimi C, Vairo D, Blond E, Restier L et al.. Carotenoids in familial hypobetalipoproteinemia disorders: Malabsorption in Caco2 cell models and severe deficiency in patients. Journal of clinical lipidology 2024. link 3 Bell DA, Pang J, Burrows S, Bates TR, van Bockxmeer FM, Hooper AJ et al.. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience. Atherosclerosis 2015. link 4 Visser ME, Dallinga-Thie GM, Pinto-Sietsma SJ, Defesche JC, Stroes ES, van der Valk PR. APOE1 mutation in a patient with type III hyperlipoproteinaemia: detailed genetic analysis required. The Netherlands journal of medicine 2012. link 5 Watts GF, Sullivan DR, van Bockxmeer FM, Poplawski N, Hamilton-Craig I, Clifton PM et al.. A new model of care for familial hypercholesterolaemia: what is the role of cardiology?. Heart, lung & circulation 2012. link 6 Araki W, Hirose S, Mimori Y, Nakamura S, Kimura J, Ohno K et al.. Familial hypobetalipoproteinaemia complicated by cerebellar ataxia and steatocystoma multiplex. Journal of internal medicine 1991. link 7 Angelin B. Metabolism of endogenous plama triglyceride in familial hypercholesterolaemia: studies of affected and unaffected siblings of two kindreds. European journal of clinical investigation 1980. link

Familial megalencephaly